<DOC>
	<DOCNO>NCT00524914</DOCNO>
	<brief_summary>Patients suffer Parkinson 's disease ( PD ) frequently experience painful sensation . We suppose painful symptom could relate neurotransmitter deficit PD . So , would like evaluate involvement dopaminergic system nociceptive processing PD patient . The objective study assess compare effect dopamine agonist administration nociceptive threshold cerebral activity use positron emission tomography ( PET scan ) two group PD patient ( 16 painful PD patient 16 pain free PD patient ) . We hypothesise dopamine agonist could normalise nociceptive threshold cerebral activity abnormal PD patient . Moreover , think painful PD patient could improve dopamine agonist pain free PD patient .</brief_summary>
	<brief_title>Apomorphine Effect Nociceptive Perception Parkinson 's : Clinical Imaging Study</brief_title>
	<detailed_description>Patients suffer Parkinson 's disease ( PD ) frequently experience painful sensation . Painful complaint various description ( muscle cramp , painful dystonia , ache , numbness , tingle , burning , vibrate , lancinating ) describe related motor symptom . Physiopathology pain PD discuss . It suggest occurrence painful symptom could part due central modification nociception basal ganglia damage dopaminergic deficit would expect eliminate inhibitory influence thalamic nociceptive activity . Recently , data show PD patient lower nociceptive threshold healthy volunteer . Our team report levodopa administration normalise nociceptive threshold decrease cerebral activity measure positron emission tomography ( PET- H215O experimental nociceptive stimulation ) several nociceptive cortical area overactive PD . These finding suggest central dopamine system play important part control nociceptive pathway PD . Nevertheless , central nervous system , levodopa could convert dopamine also noradrenaline modulate noradrenergic system . In order confirm involvement dopaminergic system nociceptive processing PD , would like assess specific drug dopamine system ( dopamine agonist , apomorphine ) PD patient . The primary objective study assess effect dopamine agonist acute administration versus placebo nociceptive subjective threshold two group PD patient ( painful PD patient , n =16 pain free PD patient , n = 16 ) . This control cross , double blind , randomise study . The secondary objective assess compare apomorphine effect objective nociceptive threshold ( nociceptive flexion reflex ) activation cerebral area use functional imaging ( TEP- H215O ) experimental nociceptive stimulation two group PD patient .</detailed_description>
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Apomorphine</mesh_term>
	<criteria>Patients suffer Parkinson 's disease PD patient Hoehn et Yahr &lt; à 3 ( Hoehn et Yahr 1967 ) PD patient treat dopaminergic drug ( levodopa , dopamine agonist , IMAOB , ICOMT… ) Painful PD patient : PD patient suffer chronic pain ( &gt; 3 month ) relate PD suggest neuropathic pain Pain free PD patient : PD patient without pain related PD . Patients chronic disease result chronic pain ( severe arthosis… . ) PD patient Hoehn et Yahr stage &gt; 3 ( Hoehn et Yahr 1967 ) Patients cancer Patients underwent PET scan last three month Pregnancy Patients contra indication use apomorphine domperidone .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Parkinson 's disease</keyword>
	<keyword>Pain</keyword>
	<keyword>Nociceptive threshold</keyword>
	<keyword>Functional imaging</keyword>
	<keyword>Cerebral activity</keyword>
	<keyword>Dopamine agonist .</keyword>
</DOC>